About this trial
Patient Profile
Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Solid Cancer (any type)
Where’s this trial being run?
Bon Secours Cork, Tallaght University Hospital, St Vincents University Hospital, and Mater Misericordiae University Hospital
Can I join this study / trial?
The first step we recommend is to talk to your doctor or the cancer trials team at your hospital. You can find contact details for cancer trials research units in Ireland here.
It’s also a good idea to print this page and bring it with you to your appointment. It can help guide the conversation and remind you of what to ask. You may also want to talk to your family or friends about your options, as they can offer support as you make decisions.
For more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | MK7339-002 / LYNK-002 |
|---|---|
| Number: | CTRIAL-IE 19-27 |
| Full Title: | A Phase 2 Study of Olaparib Monotherapy in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer |
| Principal Investigator: | Ray McDermott |
|---|---|
| Type: | Industry Sponsored |
| Sponsor: | |
| Recruitment Started: |
Global: Ireland: |
| Global Recruitment Target: | |
|---|---|
| Ireland Recruitment Target: |